Beam Therapeutics Ownership | Who Owns Beam Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Beam Therapeutics Ownership Summary


Beam Therapeutics is owned by 18.37% institutional investors, 1.19% insiders, and 80.44% retail investors. Fmr is the largest institutional shareholder, holding 11.46% of BEAM shares. ARK Innovation ETF is the top mutual fund, with 7.51% of its assets in Beam Therapeutics shares.

BEAM Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBeam Therapeutics18.37%1.19%80.44%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr11.69M11.46%$283.79M
Ark investment management11.04M10.82%$267.91B
Farallon capital management10.06M9.87%$244.23M
Blackrock7.63M9.34%$178.87M
Vanguard group9.25M9.07%$224.52M
Blackrock funding, inc. /de8.15M7.99%$197.76M
Nikko asset management americas4.83M4.74%$117.24M
Sumitomo mitsui trust4.83M4.74%$117.24M
Arch venture management4.54M4.45%$110.19M
State street4.01M3.93%$97.29M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Mwg management2.27M67.66%$55.02M
Arch venture management4.54M22.38%$110.19M
Kynam capital management, lp2.52M4.55%$61.10M
Redmile group1.39M3.28%$33.68M
Casdin capital1.60M3.24%$38.83M
Peregrine investment management267.93K3.19%$6.50M
Contrarius group1.53M1.68%$37.21M
Ark investment management11.04M1.59%$267.91B
Bellevue group2.89M1.46%$70.12M
Nikko asset management americas4.83M1.14%$117.24M

Top Buyers

HolderShares% AssetsChange
Ark investment management11.04M1.59%2.19M
Contrarius group1.53M1.68%1.53M
Ubs asset management americas1.67M0.01%1.17M
Blackrock7.63M0.00%928.75K
State street4.01M0.00%370.39K

Top Sellers

HolderShares% AssetsChange
Darwin global management---2.12M
Temasek (private)---1.81M
Fmr11.69M0.01%-1.27M
Deerfield management company, l.p. (series c)---877.81K
Morgan stanley644.76K0.00%-662.40K

New Positions

HolderShares% AssetsChangeValue
Adage capital partners gp175.00K0.01%175.00K$4.25M
Hrt financial lp162.71K0.01%162.71K$3.95M
Jump financial144.50K0.04%144.50K$3.51M
Readystate asset management lp93.93K0.10%93.93K$2.28M
Ameriprise financial88.73K0.00%88.73K$2.15B

Sold Out

HolderChange
Global financial private client-4.00
Southstate-5.00
Massmutual trust co fsb/adv-5.00
Sjs investment consulting-5.00
Ameritas advisory services-6.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202580-63.96%18,739,586-81.85%180.18%38-66.37%19-70.31%
Jun 30, 2025229-4.98%108,356,4618.36%1060.82%117-17.61%6544.44%
Mar 31, 20252421.26%101,365,37024.41%1151.18%14316.26%46-28.13%
Dec 31, 20242373.95%81,473,3153.08%981.07%12017.65%65-1.52%
Sep 30, 20242251.81%78,990,3511.88%951.08%102-5.56%664.76%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
ARK Innovation ETF7.59M7.51%-116.40K
ARK Disruptive Innovation Full Composite6.09M6.02%336.83K
Fidelity Growth Compy Commingled Pl S3.71M3.67%43.10K
Vanguard Total Stock Mkt Idx Inv3.09M3.05%-102.10K
Nikko AM ARK Disruptive Innovation A USD2.92M2.90%-98.23K
Amova ARK Disruptive Innovation A USD2.88M2.85%-38.26K
Fidelity Growth Company Fund2.78M2.74%-5.47K
Vanguard US Total Market Shares ETF2.33M2.34%2.59K
Vanguard Small Cap Index2.32M2.29%-13.15K
iShares Russell 2000 ETF2.31M2.28%-

Recent Insider Transactions


DateNameRoleActivityValue
Oct 27, 2025FMR LLC See Remark 1Sell$12.25K
Oct 01, 2025Cavanagh Bethany J SVP, Finance and TreasurerSell$11.46K
Oct 01, 2025Bellon Christine Chief Legal OfficerSell$9.15K
Oct 02, 2025Evans John M. CEOSell$615.67K
Oct 01, 2025Evans John M. CEOSell$612.65K

Insider Transactions Trends


DateBuySell
2033 Q2--
2024 Q4-2
2024 Q3-3
2024 Q2-7
2024 Q1-7

BEAM Ownership FAQ


Who Owns Beam Therapeutics?

Beam Therapeutics shareholders are primarily institutional investors at 18.37%, followed by 1.19% insiders and 80.44% retail investors. The average institutional ownership in Beam Therapeutics's industry, Biotech Stocks , is 45.24%, which Beam Therapeutics falls below.

Who owns the most shares of Beam Therapeutics?

Beam Therapeutics’s largest shareholders are Fmr (11.69M shares, 11.46%), Ark investment management (11.04M shares, 10.82%), and Farallon capital management (10.06M shares, 9.87%). Together, they hold 32.15% of Beam Therapeutics’s total shares outstanding.

Does Blackrock own Beam Therapeutics?

Yes, BlackRock owns 9.34% of Beam Therapeutics, totaling 7.63M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 178.87M$. In the last quarter, BlackRock increased its holdings by 928.75K shares, a 13.85% change.

Who is Beam Therapeutics’s biggest shareholder by percentage of total assets invested?

Mwg management is Beam Therapeutics’s biggest shareholder by percentage of total assets invested, with 67.66% of its assets in 2.27M Beam Therapeutics shares, valued at 55.02M$.

Who is the top mutual fund holder of Beam Therapeutics shares?

ARK Innovation ETF is the top mutual fund holder of Beam Therapeutics shares, with 7.51% of its total shares outstanding invested in 7.59M Beam Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools